New Insights into the In Silico Prediction of HIV Protease Resistance to Nelfinavir

The Human Immunodeficiency Virus type 1 protease enzyme (HIV-1 PR) is one of the most important targets of antiretroviral therapy used in the treatment of AIDS patients. The success of protease-inhibitors (PIs), however, is often limited by the emergence of protease mutations that can confer resista...

Descripción completa

Detalles Bibliográficos
Autores principales: Antunes, Dinler A., Rigo, Maurício M., Sinigaglia, Marialva, de Medeiros, Rúbia M., Junqueira, Dennis M., Almeida, Sabrina E. M., Vieira, Gustavo F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909182/
https://www.ncbi.nlm.nih.gov/pubmed/24498124
http://dx.doi.org/10.1371/journal.pone.0087520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909182/
https://www.ncbi.nlm.nih.gov/pubmed/24498124
http://dx.doi.org/10.1371/journal.pone.0087520

Ejemplares similares